 "Pharma stocks, firms, earnings")
Shares of select pharmaceutical companies rallied up to 8 per cent on the BSE in Monday’s intra-day trade after several companies signed voluntary license for Pfizer Inc's Covid-19 oral treatment– nirmatrelvir.
Nirmatrelvir in combination with ritonavir co-pack has received emergency use/conditional authorization for Covid-19 treatment in certain populations by the US FDA and the UK Medicines and Healthcare products Regulatory Agency (UK MHRA and nearly 50 other countries).
Nirmatrelvir in combination with ritonavir co-pack has received emergency use/conditional authorization for Covid-19 treatment in certain populations by the US FDA and the UK Medicines and Healthcare products Regulatory Agency (UK MHRA and nearly 50 other countries).
Among individual stocks, Aurobindo Pharma was the top gainer, which rallied 8 per cent to Rs 688.90 on the BSE in intra-day trade. The stock has recovered 18 per cent
